Dendritic cell-targeting chemokines inhibit colorectal cancer progression

AIM: Recent progress in cancer immunotherapy has shown its promise and prompted researchers to develop novel therapeutic strategies. Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating adaptive anti-tumor immunity, therefore a promising target for cancer treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Pengkun, Zhou, Yunyi, Wang, Zhixue, Gui, Liming, Ma, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834269/
https://www.ncbi.nlm.nih.gov/pubmed/36654820
http://dx.doi.org/10.37349/etat.2022.00115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834269/
https://www.ncbi.nlm.nih.gov/pubmed/36654820
http://dx.doi.org/10.37349/etat.2022.00115

Ejemplares similares